Exelon Crecimiento futuro
Future controles de criterios 1/6
Se prevé un crecimiento anual de los beneficios y los ingresos de Exelon de 6.3% y 2.5% por año respectivamente. Se prevé que el BPA crezca en un 5.9% al año. Se espera que la rentabilidad financiera sea de 9.7% en 3 años.
Información clave
6.3%
Tasa de crecimiento de los beneficios
5.9%
Tasa de crecimiento del BPA
Crecimiento de los beneficios de Electric Utilities | 9.2% |
Tasa de crecimiento de los ingresos | 2.5% |
Rentabilidad financiera futura | 9.7% |
Cobertura de analistas | Good |
Última actualización | 24 Apr 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Exelon Corporation's (NASDAQ:EXC) Shareholders Might Be Looking For Exit
Apr 29Exelon: Rate-Base Scale, Cost Management Drive Upside Potential
Mar 29A Look At The Fair Value Of Exelon Corporation (NASDAQ:EXC)
Mar 18Risks To Shareholder Returns Are Elevated At These Prices For Exelon Corporation (NASDAQ:EXC)
Jan 08A Look At The Fair Value Of Exelon Corporation (NASDAQ:EXC)
Oct 27Are Exelon Corporation (NASDAQ:EXC) Investors Paying Above The Intrinsic Value?
Jul 24Exelon (NASDAQ:EXC) Is Increasing Its Dividend To $0.36
Apr 29Exelon Corporation's (NASDAQ:EXC) Intrinsic Value Is Potentially 21% Below Its Share Price
Apr 10Exelon's (NASDAQ:EXC) Shareholders Will Receive A Bigger Dividend Than Last Year
Feb 18Does This Valuation Of Exelon Corporation (NASDAQ:EXC) Imply Investors Are Overpaying?
Dec 30Estimating The Intrinsic Value Of Exelon Corporation (NASDAQ:EXC)
Sep 26Exelon: A Pure Play Transmission Firm Poised To Benefit From Utility Grid Transformation
Aug 31Exelon Q2 2022 Earnings Preview
Aug 02We Think Exelon (NASDAQ:EXC) Is Taking Some Risk With Its Debt
Aug 01Exelon Corporation declares $0.3375 dividend
Jul 26A Look At The Intrinsic Value Of Exelon Corporation (NASDAQ:EXC)
Jun 21Exelon's Corporate Transactions Will Likely Imply Higher Stock Price
May 17Exelon (NASDAQ:EXC) Has A Somewhat Strained Balance Sheet
May 02Exelon Corporation: On The Verge Of Proving Its Worth
Apr 15Exelon Corporation (NASDAQ:EXC) Analysts Just Cut Their EPS Forecasts Substantially
Feb 04Is There An Opportunity With Exelon Corporation's (NASDAQ:EXC) 44% Undervaluation?
Jan 16Does Exelon (NASDAQ:EXC) Have A Healthy Balance Sheet?
Jan 03Exelon (NASDAQ:EXC) Has Announced A Dividend Of US$0.38
Nov 04Returns At Exelon (NASDAQ:EXC) Appear To Be Weighed Down
Oct 15Avoided Nuclear Shutdowns, Higher Power Prices Make Exelon A Buy
Oct 05Is Exelon (NASDAQ:EXC) Using Too Much Debt?
Sep 28Growth Investors: Industry Analysts Just Upgraded Their Exelon Corporation (NASDAQ:EXC) Revenue Forecasts By -2.1%
Aug 05Exelon (NASDAQ:EXC) Has Announced A Dividend Of US$0.38
Jul 30Exelon (NASDAQ:EXC) Will Be Looking To Turn Around Its Returns
Jul 07Previsiones de crecimiento de beneficios e ingresos
Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
---|---|---|---|---|---|
12/31/2026 | 22,736 | 2,826 | -676 | 7,065 | 11 |
12/31/2025 | 22,004 | 2,638 | -1,318 | 6,496 | 11 |
12/31/2024 | 21,494 | 2,449 | -1,013 | 6,039 | 10 |
12/31/2023 | 21,727 | 2,328 | -2,705 | 4,703 | N/A |
9/30/2023 | 21,026 | 2,143 | -3,487 | 4,021 | N/A |
6/30/2023 | 19,892 | 2,120 | -3,934 | 3,391 | N/A |
3/31/2023 | 19,314 | 2,242 | -3,534 | 3,572 | N/A |
12/31/2022 | 19,078 | 2,053 | -2,277 | 4,870 | N/A |
9/30/2022 | 18,836 | 1,933 | -4,178 | 3,012 | N/A |
6/30/2022 | 18,852 | 1,686 | -2,334 | 5,114 | N/A |
3/31/2022 | 18,633 | 1,473 | -1,708 | 6,055 | N/A |
12/31/2021 | 17,938 | 1,493 | -4,969 | 3,012 | N/A |
9/30/2021 | 21,628 | 1,540 | -4,258 | 4,154 | N/A |
6/30/2021 | 25,619 | 1,612 | -5,622 | 2,693 | N/A |
3/31/2021 | 28,924 | 1,881 | -6,278 | 1,894 | N/A |
12/31/2020 | 16,663 | 1,108 | -3,813 | 4,235 | N/A |
9/30/2020 | 33,267 | 2,376 | -2,154 | 5,482 | N/A |
6/30/2020 | 33,344 | 2,648 | -1,049 | 6,441 | N/A |
3/31/2020 | 33,708 | 2,611 | -737 | 6,695 | N/A |
12/31/2019 | 34,438 | 2,936 | -630 | 6,659 | N/A |
9/30/2019 | 34,904 | 2,311 | -85 | 7,368 | N/A |
6/30/2019 | 35,377 | 2,271 | 217 | 7,673 | N/A |
3/31/2019 | 35,762 | 2,327 | 445 | 8,186 | N/A |
12/31/2018 | 35,978 | 2,005 | 896 | 8,644 | N/A |
9/30/2018 | 35,555 | 3,737 | 900 | 8,482 | N/A |
6/30/2018 | 34,920 | 3,827 | 851 | 8,454 | N/A |
3/31/2018 | 34,511 | 3,381 | 453 | 7,908 | N/A |
12/31/2017 | 33,558 | 3,779 | -104 | 7,480 | N/A |
9/30/2017 | 33,054 | 2,111 | N/A | 6,755 | N/A |
6/30/2017 | 33,287 | 1,778 | N/A | 6,787 | N/A |
3/31/2017 | 32,532 | 1,951 | N/A | 8,046 | N/A |
12/31/2016 | 31,366 | 1,121 | N/A | 8,461 | N/A |
9/30/2016 | 30,187 | 1,240 | N/A | 9,305 | N/A |
6/30/2016 | 28,587 | 1,378 | N/A | 8,200 | N/A |
3/31/2016 | 28,192 | 1,749 | N/A | 7,599 | N/A |
12/31/2015 | 29,447 | 2,269 | N/A | 7,616 | N/A |
9/30/2015 | 30,002 | 1,978 | N/A | 6,488 | N/A |
6/30/2015 | 29,513 | 2,342 | N/A | 6,675 | N/A |
3/31/2015 | 29,022 | 2,226 | N/A | 5,782 | N/A |
12/31/2014 | 27,429 | 1,623 | N/A | 4,457 | N/A |
9/30/2014 | 26,336 | 2,099 | N/A | 5,592 | N/A |
6/30/2014 | 25,926 | 1,845 | N/A | 5,756 | N/A |
3/31/2014 | 26,043 | 1,813 | N/A | 5,649 | N/A |
12/31/2013 | 24,888 | 1,719 | N/A | 6,343 | N/A |
9/30/2013 | 24,979 | 1,602 | N/A | 5,951 | N/A |
6/30/2013 | 25,056 | 1,160 | N/A | 5,756 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (6.3% al año) de EXC es superior a la tasa de ahorro (2.3%).
Beneficios vs. Mercado: Se prevé que los beneficios (6.3% al año) de EXC crezcan menos que el mercado US (14.7% al año).
Beneficios de alto crecimiento: Se prevé que los beneficios de EXC crezcan, pero no significativamente.
Ingresos vs. Mercado: Se prevé que los ingresos (2.5% al año) de EXC crezcan más despacio que el mercado de US (8.1% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 2.5% al año) de EXC crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Se prevé que la rentabilidad financiera de EXC sea baja dentro de 3 años (9.7%).